An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT06342414
- Status
- Recruiting
Conditions
- Cholangiocarcinoma
- Hepatic Cancer
- Hepatic Carcinoma
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- Primary Liver Cancer
- Primary Liver Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ELUCIDATE — DIAGNOSTIC_TESTELUCIDATE (Evaluation of Liver Cholangiocarcinoma Intrahepatic)
Study Details
It is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinicians differentiate these two cancers before surgery.
Key Dates
- Start date
- Mar 15, 2024
- Status verified
- Apr 2026
- Primary completion
- Jun 18, 2026
- Completion
- Jun 18, 2026
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Hepatocellular Carcinoma (Training)A cohort of patients with histologically confirmed hepatocellular carcinoma (HCC)
- Arm: Intrahepatic Cholangiocarcinoma (Training)A cohort of patients with histologically confirmed intrahepatic cholangiocarcinoma (ICC)
- Arm: Hepatocellular Carcinoma (Validation)A cohort of patients with histologically confirmed hepatocellular carcinoma (HCC)
- Arm: Intrahepatic Cholangiocarcinoma (Validation)A cohort of patients with histologically confirmed intrahepatic cholangiocarcinoma (ICC)
Primary Outcome Measure
Sensitivity [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Ajay Goel, PhD6262183452
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | Caiming Xu, MD, PhD (SUB_INVESTIGATOR) Yoh Asahi, MD (PRINCIPAL_INVESTIGATOR) Ajay Goel, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Duarte, CA
By condition
By specialty
By research site
Related Studies
- Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerPHASE1/PHASE2 · Recruiting · Teclison Ltd. · Palo Alto, California
- Combination of TATE and PD-1 Inhibitor in Liver CancerPHASE2 · Recruiting · Teclison Ltd. · Orange, California
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPHASE1 · Recruiting · BioEclipse Therapeutics · Scottsdale, Arizona